Metabolic dependencies of breast cancer cells - UCL Discovery

Pts may have received prior VEGFR-targeted treatment. Pts were treated with a starting dose of E7080 24 mg once daily until disease progression.







(12) PATENT (19) AUSTRALIAN PATENT OFFICE (11) Application ...
... 3.4. Preexisting impairments of health status, making the conduct of ... EGF-receptor, c-erbB-2 oncoprotein, TGF-alpha ) or an increase ...
SIOP ? LGG 2004 Cooperative multicenter Study for Children and ...
... epidermal growth factor (EGF) receptor signalling via EGF or transforming growth factor (TGF)-?, and to a number of cytokines including TGF-?, fibroblast ...
Dissertation Alexander Kanitz - Research Collection
Binding of a growth factor [e.g. epidermal growth factor (EGF)] to the corresponding receptor tyrosine kinase (RTK) leads to its oligomerisation and ...



Autres Cours:

Engineering bispecific antibodies for targeted delivery of cytotoxin